SEARCH

SEARCH BY CITATION

Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

P. Greaves, H. Oakervee, S. S. C. Kon, R. Jones and N. Farah

Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

S. A. G. M. Cillessen, C. J. L. M. Meijer, G. J. Ossenkoppele, K. C. M. Castricum, A. H. Westra, P. Niesten, J. J. F. Muris, H. F. Nijdam, K. G. van der Hem, M. Flens, E. Hooijberg and J. J. Oudejans

Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

G. Georgiou, V. Karali, C. Zouvelou, E. Kyriakou, M. Dimou, S. Chrisochoou, P. Greka, D. Dufexis, E. Vervesou, E. Dimitriadou, A. Efthymiou, L. Petrikkos, K. Dima, K. Lilakos and P. Panayiotidis

Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

J. F. W. Keuren, E. J. P. Megdeleyns, J.W. P. Gowers-Riemslag, T. Lindhout and J. Curvers

Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

G. A. Allen, M. Hoffman, H. R. Roberts and D. M. Monroe

Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

K. M. Bowles, D. M. Bloxham, D. J. Perry and T. P. Baglin

Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

C. Martin, G. J. Bridger and S. M. Rankin

Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

  1. Top of page
  2. Posterior reversible encephalopathy syndrome following anti-lymphocyte globulin treatment for severe aplastic anaemia
  3. Retinopathy of anaemia in T-cell lymphoma
  4. Proteasome inhibition as novel treatment strategy in leukaemia
  5. Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now
  6. Human soluble TRAIL/Apo2L induces apoptosis in a subpopulation of chemotherapy refractory nodal diffuse large B-cell lymphomas, determined by a highly sensitive in vitro apoptosis assay
  7. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up, or acute myeloid leukaemia transformation: incidence and their prognostic significance
  8. Effects of storage induced platelet microparticles on the initiation and propagation phase of blood coagulation
  9. Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia
  10. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura
  11. Structural analogues of AMD3100 mobilise haematopoietic progenitor cells from bone marrow in vivo according to their ability to inhibit CXCL12 binding to CXCR4 in vitro
  12. Fetal hepatic haematopoiesis is modulated by arterial blood flow to the liver

S. M. Kunisaki, H. Azpurua, J. R. Fuchs, S. C. Graves, D. Zurakowski and D. O. Fauza